These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 10574181)
1. The design and synthesis of potent inhibitors of hepatitis C virus NS3-4A proteinase. Attwood MR; Bennett JM; Campbell AD; Canning GG; Carr MG; Conway E; Dunsdon RM; Greening JR; Jones PS; Kay PB; Handa BK; Hurst DN; Jennings NS; Jordan S; Keech E; O'Brien MA; Overton HA; King-Underwood J; Raynham TM; Stenson KP; Wilkinson CS; Wilkinson TC; Wilson FX Antivir Chem Chemother; 1999 Sep; 10(5):259-73. PubMed ID: 10574181 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics. Lin C; Prágai BM; Grakoui A; Xu J; Rice CM J Virol; 1994 Dec; 68(12):8147-57. PubMed ID: 7966606 [TBL] [Abstract][Full Text] [Related]
3. Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography. Sudo K; Inoue H; Shimizu Y; Yamaji K; Konno K; Shigeta S; Kaneko T; Yokota T; Shimotohno K Antiviral Res; 1996 Aug; 32(1):9-18. PubMed ID: 8863991 [TBL] [Abstract][Full Text] [Related]
4. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase. De Francesco R; Pessi A; Steinkühler C Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity. Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919 [TBL] [Abstract][Full Text] [Related]
6. The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay. Lin C; Rice CM Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7622-6. PubMed ID: 7644466 [TBL] [Abstract][Full Text] [Related]
7. Kinetic and structural analyses of hepatitis C virus polyprotein processing. Bartenschlager R; Ahlborn-Laake L; Mous J; Jacobsen H J Virol; 1994 Aug; 68(8):5045-55. PubMed ID: 8035505 [TBL] [Abstract][Full Text] [Related]
8. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. Grakoui A; McCourt DW; Wychowski C; Feinstone SM; Rice CM J Virol; 1993 May; 67(5):2832-43. PubMed ID: 8386278 [TBL] [Abstract][Full Text] [Related]
10. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. Bartenschlager R; Lohmann V; Wilkinson T; Koch JO J Virol; 1995 Dec; 69(12):7519-28. PubMed ID: 7494258 [TBL] [Abstract][Full Text] [Related]
11. An in vitro assay for hepatitis C virus NS3 serine proteinase. Bouffard P; Bartenschlager R; Ahlborn-Laake L; Mous J; Roberts N; Jacobsen H Virology; 1995 May; 209(1):52-9. PubMed ID: 7747484 [TBL] [Abstract][Full Text] [Related]
12. Product inhibition of the hepatitis C virus NS3 protease. Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031 [TBL] [Abstract][Full Text] [Related]
13. Solid phase synthesis of aminoboronic acids: potent inhibitors of the hepatitis C virus NS3 proteinase. Dunsdon RM; Greening JR; Jones PS; Jordan S; Wilson FX Bioorg Med Chem Lett; 2000 Jul; 10(14):1577-9. PubMed ID: 10915055 [TBL] [Abstract][Full Text] [Related]
14. Identification of amino acid variants in the hepatitis C virus non-structural protein 4A. Bermúdez-Aguirre AD; Padilla-Noriega L; Zenteno E; Reyes-Leyva J Tohoku J Exp Med; 2009 Jul; 218(3):165-75. PubMed ID: 19561386 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus NS3/4A protease. Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580 [TBL] [Abstract][Full Text] [Related]
16. Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase. Bartenschlager R; Ahlborn-Laake L; Yasargil K; Mous J; Jacobsen H J Virol; 1995 Jan; 69(1):198-205. PubMed ID: 7983710 [TBL] [Abstract][Full Text] [Related]
17. Probing of exosites leads to novel inhibitor scaffolds of HCV NS3/4A proteinase. Shiryaev SA; Cheltsov AV; Strongin AY PLoS One; 2012; 7(7):e40029. PubMed ID: 22768327 [TBL] [Abstract][Full Text] [Related]
18. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A. Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351 [TBL] [Abstract][Full Text] [Related]
19. The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. Lin C; Wu JW; Hsiao K; Su MS J Virol; 1997 Sep; 71(9):6465-71. PubMed ID: 9261364 [TBL] [Abstract][Full Text] [Related]
20. Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction. Leinbach SS; Bhat RA; Xia SM; Hum WT; Stauffer B; Davis AR; Hung PP; Mizutani S Virology; 1994 Oct; 204(1):163-9. PubMed ID: 8091650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]